Skip to main content
Premium Trial:

Request an Annual Quote

Steve MacMillan, David LaVance

Hologic President and CEO Steve MacMillan has been appointed chairman of the company's board, following the resignation of David LaVance, who has told the board he will not stand for reelection at the 2016 annual shareholders' meeting. LaVance has been on Hologic's board since 2002.

Additionally, Elaine Ullian, a current director at Hologic, has been appointed the lead independent director. Ullian is the former president and CEO of the Boston Medical Center. 

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.